Trude Steinsvik (T Steinsvik)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Atrial Fibrillation

Community Acquired Pneumonia

Heart Rate Variability

Angiotensin Converting Enzyme

Top Venues

Clinical chemistry

Infectious diseases (London, England)

European heart journal. Cardiovascular pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Nasir Saeed, Ole-Thomas Steiro, Jørund Langørgen, Hilde L Tjora, Rune O Bjørneklett, Øyvind Skadberg, Vernon V S Bonarjee, Øistein R Mjelva, Tone M Norekvål, Trude Steinsvik, Kjell Vikenes, Torbjørn Omland, Kristin Moberg Aakre
Diagnosing Myocardial Injury in an Acute Chest Pain Cohort; Long-Term Prognostic Implications of Cardiac Troponin T and I. Clinical chemistry (2024)
K Enge, Arnljot Tveit, S Enger, S Onarheim, Are Hugo Pripp, Peter Selmer Rønningen, Magnar G Solberg, R Byrkjeland, K Andresen, A Halsen, Hanne Aaserud Aulie, Trude Steinsvik, C Hall, S R Ulimoen
Diltiazem reduces levels of NT-proBNP and improves symptoms compared with metoprolol in patients with permanent atrial fibrillation. European heart journal. Cardiovascular pharmacotherapy (2024)
Kjersti Oppen, Thor Ueland, Annika Elisabet Michelsen, Pål Aukrust, Trude Steinsvik, Øyvind Skadberg, Cato Brede, William Ward Siljan, Einar Husebye, Jan Cato Holter, Lars Heggelund
Hepcidin predicts 5-year mortality after community-acquired pneumonia. Infectious diseases (London, England) 54 (6) (2022)